| Match Context and Document information |
These search terms are highlighted: dea verification
| URL: | https://www.deadiversion.usdoj.gov/faq/civil-unrest.html |
|---|
| Depth: | 2 clicks away from Home |
|---|
| Size: | 98,113 bytes |
|---|
| Modified: | 2024-05-29 08:47:20 |
|---|
| Categories: | -None- |
|---|
| Title: | Diversion Control Division | Civil Unrest/Looting Registration Guidance
Documents Q&A |
|---|
| Description: | -None- |
|---|
| Keywords: | Diversion Control Division |
|---|
| Meta data: | -None- |
|---|
| Body: | DIVERSION CONTROL DIVISION
DEA.Registration.Help@dea.gov
1.800.882.9539
Search
Home
About Us
Program Description
Customer Service Plan
DEA Forms & Applications
Mailing Addresses
Meeting & Events
Privacy Notice
What's New
Registration
Registration
CMEA Required Training & Self-Certification
Quota Applications
Marihuana Growers Information
Schedule I Controlled Substances Research Information
Notice of Registration
Reporting
ARCOS
BCM Online
Chemical Import/Export
Declarations
CSOS
Theft/Loss Reporting
Import/Export
Medical Missions
Quotas
Registrant Record of
Controlled Substances Destroyed
Regulated Machines
(Tableting and Encapsulating)
Reports Required by 21 CFR
SORS
Submit a Tip to DEA
Year-end Reports
Resources
Administrative Actions
Chemical Control Program
CMEA (Combat Meth
Epidemic Act)
Controlled Substances Schedules
DEA Regulatory Priorities
DEA TOX
Drug Disposal Information
Drug & Chemical Information
EPCS (Electronic Prescriptions for
Controlled Substances)
Federal Register Notices
Guidance Document Portal
Medications for Opioid Use Disorder
National Prescription Drug
Take Back Day
NFLIS
OPIOID (PHE) Information
Publications & Manuals
Questions & Answers
Telemedicine
Title 21 Code of Federal Regulations
Title 21 USC Codified CSA
Contact Us
Civil Unrest/Looting Registration Guidance Documents Q&A
Home
Resources
Questions & Answers
Civil Unrest/Looting Registration Guidance Documents Q&A
Damage to Pharmacies
Question: My pharmacy was ransacked and controlled substances and/or SLCPs
were stolen or destroyed. How long do I have to report the theft and loss
to DEA?
Answer: Reporting the theft and loss of controlled substances: Title 21 CFR
1301.76(b) requires that a registrant notify their local DEA Division Field
Office, in writing, within one business day of discovery of such theft or
loss of controlled substances. A registrant can meet the "in writing"
requirement by sending an email to the below listed DEA point of contact
for your state or region. The registrant must also file a complete and
accurate DEA Form 106, Report of Theft or Loss of Controlled Substances,
online within 45 days after discovery of the theft or loss.
Reporting the theft and loss of SLCPs: Title 21 CFR 1314.15 requires that a
regulated person must, whenever possible, orally report to their DEA
Division Office any unusual or excessive loss or disappearance of an SLCP
at the earliest practicable opportunity after the regulated person becomes
aware of the circumstances involved. A written report of loss must be filed
within 15 days after the regulated person becomes aware of the
circumstances of the event. 21 CFR 1314.15(c). Title 21 CFR 1314.15(e)
provides a suggested format for the report. EO-DEA157R1, DEA-DC-033R1,
February 22, 2024
In lieu of contacting the SAC as required by 21 CFR 1314.15(a), reporting
requirements can be satisfied by contacting the individuals below:
Below is a listed of each states DEA point of contact for theft or losses
during the civil unrest:
State DEA POC Email Address
Alabama Diversion Investigator (DI) Faith King Faith.F.King@dea.gov
Alaska Group Supervisor (GS) Shane Pitts Shane.F.Pitts@dea.gov
Arizona DI Hoang Vo Hoang.A.Vo@dea.gov
Arkansas DI Matthew D. Bissonnette Matthew.D.Bissonnette@dea.gov
California (Middle) DI Veronica Corona Veronica.Corona@dea.gov
California (Northern) GS Jennifer Gueye Jennifer.D.Gueye@dea.gov
California (Southern) San Diego & Imperial Counties DI Pamela S. Meyer Pamela.S.Meyer@dea.gov
Caribbean Diversion Program Manager (DPM) Antonio Guzman Antonio.R.Guzman@dea.gov
Colorado GS Angie Pickrel Angie.K.Pickrel@dea.gov
Connecticut DI Jesus Cruz Jesus.J.Cruz@dea.gov
Delaware DI Nicholas Caruso Nicholas.D.Caruso@dea.gov
District of Columbia GS William Reed William.T.Reed@dea.gov
Florida DPM William Stockmann William.P.Stockmann@dea.gov
Georgia (Central to Northern GS Brian Curtis Brian.A.Curtis@dea.gov
Georgia (Central to Southern GS Anthony Richards Anthony.J.Richards@dea.gov
Hawaii GS Anastasia Martin Anastasia.T.Martin@dea.gov
Idaho GS Tyler Warner Tyler.D.Warner@dea.gov
Illinois (Northern half) GS Megan N. Almendinger Megan.N.Almendinger@dea.gov
Illinois (Southern half) DI Mark Grman Mark.J.Grman@dea.gov
Indiana (Northern half) DI Jennifer Tucker Jennifer.L.Tucker@dea.gov
Indiana (Southern half) GS Billy P. Lane Billy.P.Lane@dea.gov
Iowa DI Amy Nelson Amy.J.Nelson@dea.gov
Kansas GS Marie Coulter Marie.L.Coulter@dea.gov
Kentucky GS Ben Vinson & DPM Christopher A. Kresnak Benjamin.S.Vinson@dea.gov & Christopher.A.Kresnak@dea.gov
Louisiana DI Christopher Martinez Christopher.M.Martinez@dea.gov
Maine DI Emma Hinnigan Emma.J.Hinnigan@dea.gov
Maryland GS Leroy Hartley Leroy.Hartley@dea.gov
Massachusetts DI Taylor McCarty Taylor.A.McCarty@dea.gov
Michigan GS Jason M. Smith Jason.M.Smith@dea.gov
Minnesota GS Summer Schwab Summer.M.Schwab@dea.gov
Mississippi DI William Wilson William.K.Wilson@dea.gov
Missouri DI Mark Grman Mark.J.Grman@dea.gov
Montana DI Christopher Davis Christopher.S.Davis2@dea.gov
Nebraska GS Shannon Keller Shannon.B.Keller@dea.gov
Nevada GS Cynthia Highsmith Cynthia.R.Highsmith@dea.gov
New Hampshire DI Frank Borelli Frank.J.Borelli@dea.gov
New Jersey (Camden) DI Young West Young.J.West@dea.gov
New Jersey DI Michael Deignan Michael.J.Deignan@dea.gov
New Mexico DPM Heather McMurry Heather.McMurry@dea.gov
New York City & Surrounding DI Kimberly Hadinata Kimberly.P.Hadinata@dea.gov
New York (Long Island) DI Richard DAoust Richard.J.DAoust@dea.gov
New York Upstate DI Laurence A. Martin Laurence.X.Martin@dea.gov
North Carolina (Central to Western DI Charles Carpenter Charles.B.Carpenter@dea.gov
North Carolina (Central to Eastern) - Raleigh GS Tracy LaFevers Tracy.M.LaFevers@dea.gov
North Dakota GS Summer Schwab Summer.M.Schwab@dea.gov
Ohio Central - Columbus GS Jason M. Smith Jason.M.Smith@dea.gov
Ohio Southern-Cincinnati GS Jason M. Smith Jason.M.Smith@dea.gov
Ohio Northern - Cleveland GS Jason M. Smith Jason.M.Smith@dea.gov
Oklahoma DPM Inez Davis Inez.M.Davis@dea.gov
Oregon Acting GS Rica Rachut Rica.M.Rachut@dea.gov
Pennsylvania (Eastern) DI Alida Lefebvre Alida.M.Lefebvre@dea.gov
Pennsylvania (Western) GS Lewis Colosimo Lewis.D.Colosimo@dea.gov
Pennsylvania (Middle) DI Colin Miller Colin.D.Miller@dea.gov
Rhode Island DI Thomas Cook Thomas.A.Cook@dea.gov
South Carolina GS Kendra Toussaint Kendra.V.Toussaint@dea.gov
South Dakota GS Shannon Keller Shannon.B.Keller@dea.gov
Tennessee GS James Stevens & DPM Christopher A. Kresnak James.N.Stevens@dea.gov & Christopher.A.Kresnak@dea.gov
Texas (North) DPM Inez Davis Inez.M.Davis@dea.gov
Texas (South) A/GS Carolina Vazquez Carolina.Vazquez-Lopez@dea.gov
Texas (West) DPM Heather McMurry Heather.McMurry@dea.gov
Utah DI Darrick Snyder Darrick.J.Snyder@dea.gov
Vermont DI Christopher Paquette Christopher.L.Paquette@dea.gov
Virginia (Eastern) GS Edward Logan Edward.M.Logan@dea.gov
Virginia (Central) GS Steven Hallenbeck Steven.M.Hallenbeck@dea.gov
Virginia (Western) GS Jennifer Reed Jennifer.Reed5@dea.gov
Washington Acting GS Rica Rachut Rica.M.Rachut@dea.gov
West Virginia GS James Hischar & DPM Christopher A. Kresnak James.J.Hischar@dea.gov & Christopher.A.Kresnak@dea.gov
Wisconsin GS Laura Reid Laura.Reid@dea.gov
Wyoming DI Tyler Tracy Tyler.L.Tracy@dea.gov
EO-DEA157R1, DEA-DC-033R1, February 22, 2024
Question: Some pharmacies have experienced looting and extreme damage
during recent rioting. Medications were thrown on the floor, and bottles
were broken, making it unsafe and difficult to identify loose pills. How
can we safely destroy controlled substances and maintain recordkeeping
compliance?
Answer: DEA regulations authorize pharmacies to destroy controlled
substances, or cause controlled substances to be destroyed, in a variety of
ways, so long as the pharmacy acts in accordance with all other applicable
federal, state, tribal, and local laws and regulations, and the controlled
substances are rendered non-retrievable. See, e.g., 21 CFR 1317.05(a),
1317.90, 1317.95. In most circumstances, however, DEA recommends that a
pharmacy take the following steps to allow for the safe destruction of
controlled substances and maintain records:
1) Contact a DEA-registered reverse distributor who will work with you to
receive the controlled substances you need destroyed.
2) Safely transfer the controlled substances (and any debris mixed in with
them) into containers, and seal the containers.
3) Sealed containers should be given a serial number or item number for
tracking purposes.
4) You should document your transfer of these sealed containers to a
reverse distributor on an invoice. The invoice should note the number of
sealed containers and each container's serial number. This will act as
the record of receipt for the reverse distributor. 21 CFR 1304.21(d).
5) Sealed containers should then be sent to a reverse distributor through a
common or contract carrier or picked up by a reverse distributor under
their standard operating procedures. 21 CFR 1317.05(a)(2). If a common or
contract carrier is used, sealed containers must only be delivered to the
reverse distributor's registered location. 21 CFR 1317.15(b)(2)(i).
6) The reverse distributor will destroy entire sealed containers and
document the destruction on a DEA Form 41. 21 CFR 1304.21(e).
7) To account for lost, damaged, or stolen controlled substances (including
through looting) that need to be destroyed, you should file a DEA Form 106
(report of Theft or Loss of Controlled Substances) based on pre-riot
inventories and other pharmacy records. 21 CFR 1301.76(b). Forms may be
accessed through this DEA link. You are required to maintain complete and
accurate records. 21 U.S.C. 827(a)(3). EO-DEA210, July 13, 2020, DEA-DC-042
Transfer of Prescriptions
Question: I am a pharmacist who is unable to dispense schedule II
prescription medication due to civil unrest. How can my patients obtain
their controlled substance medications?
Answer: If you are unable to conduct business, it is recommended that you
advise your patients of the following regarding how they may obtain their
schedule II prescription medications from another pharmacy.
If your patient received a paper prescription that you have not filled, you
generally may simply suggest that your patient take that prescription to
another pharmacy. Your patients also may contact their doctor to obtain a
new paper or electronic prescription for a schedule II controlled
substance. The original pharmacy should document on the original schedule
II prescription that it is void, the date the prescription was voided, and
the reason for voiding the prescription. See 21 CFR 1311.200(h) (requiring
a pharmacy that receives an original electronic prescription which it
cannot dispense to mark the electronic version as voided or cancelled). In
addition, in the case of an emergency situation, a practitioner may issue
an emergency oral prescription to a pharmacy subject to certain
requirements. 21 CFR 1306.11(d). Please refer to DEA's guidance regarding
certain limited exceptions to these emergency oral prescription
requirements during the COVID-19 Public Health Emergency on the DEA
COVID-19 Information Page.
DEA recommends that you contact your state pharmacy authority to ensure
that you remain in compliance with state pharmacy laws and guidance. Please
contact your local DEA Field Office for additional information.
EO-DEA207, June 6, 2020, DEA-DC-041
Expedited Replacement of DEA Form 222s
Question: My pharmacy was looted and incurred property damage. The looters
stole or destroyed the pharmacies DEA Form 222s beyond use, could the DEA
expedite shipment of new DEA Forms 222?
Answer: DEA would be happy to assist, please contact DEA's registration
unit at: DEA.Registration.Help@dea.gov. Please include in the email your
name, DEA Registration number, contact phone number, and reason for the
emergency shipment of DEA Form 222s. You may also telephone the
Registration unit at (800) 882-9539. EO-DEA158, June 3, 2020
Registration of New Building at Same Address (Pharmacy)
Question: My pharmacy was destroyed or heavily damaged during the civil
unrest. I would like to open a temporary pharmacy at the same physical
address as my current pharmacy. Am I required to obtain a new DEA
registration while my pharmacy is being repaired or rebuilt?
Answer: If a pharmacy's temporary structure would be located at the same
registered address (e.g., a temporary structure located at the address's
parking lot), it is permissible to operate a temporary pharmacy at the same
registered address under certain conditions. If a temporary pharmacy is
deployed, it is recommended that you notify your local DEA Field Office of
the new security established at your temporary location. The temporary
pharmacy is authorized to operate under the same DEA number that was issued
to the destroyed or heavily damaged pharmacy. The temporary structure must
comply with all regulatory requirements applicable to registered
pharmacies. In particular, please note that security controls for
controlled substances stored or dispensed in the temporary structure must
be adequate to comply with 21 CFR 1301.71, including the requirements
specifically listed at 21 CFR 1301.75(b).
If the destroyed or heavily damaged pharmacy is temporarily moved to a
different physical address, the address on the DEA registration for the
pharmacy must be modified to reflect the new physical address. 21 CFR
1301.51. The DEA registration may be modified to the new physical address
by using the online modification form. Also, registrants should ensure that
applicable state and local law allows for this type of transfer. Again, it
is recommended that the pharmacy personnel contact the local DEA Field
Office for assistance in DEA record-keeping and security requirements. As
with temporary structures at the same address, the temporary location at
the new address must also comply with all regulatory requirements
applicable to registered pharmacies, including security control
requirements. EO-DEA156, June 4, 2020
Narcotic Treatment Program (NTP)
Question: Our Narcotic Treatment Program (NTP) is located in an area of
civil unrest and clients are unable to get to the clinic for dosing. What
are our options for dosing at alternate locations?
Answer: While not necessarily an exhaustive list, the following are a few
suggested options for providing doses to NTP patients during civil unrest:
1. An NTP may coordinate with another NTP for guest dosing. To do so, the
NTP may refer patients to another NTP for dosing.
2. At this time, under the COVID-19 public health emergency, DEA is
permitting NTPs to repeatedly use the same alternate location to deliver
take-home methadone doses to their patients without separately registering
that location with DEA. Off-site location delivery of methadone is only
available for patients who are authorized to take home doses of methadone
to use on their own and is not available for patients who must have
individual doses of methadone administered or dispensed directly to them by
the OTP each day. For additional information please see the DEA guidance
document on registered NTPs dispensing methadone during the public health
emergency. DEA is also permitting NTPs to regularly use the same off-site
location to deliver take-home buprenorphine doses to their patients without
separately registering that location with DEA during the public health
emergency. For additional information on providing take-home buprenorphine
doses, please see the DEA guidance document on registered NTPs dispensing
buprenorphine. The delivery of take-home methadone and buprenorphine doses
through off-site unregistered locations is subject to the conditions and
limitations described in the DEA guidance documents at the links above.
3. An NTP may also authorize an NTP staff member, law enforcement officer,
or National Guard personnel to make doorstop deliveries of take-home doses
of methadone or buprenorphine in an approved lock-box, as allowed by
another exception granted by DEA during this public health emergency.
Please see the letter announcing this exception. Delivery of take-home
doses in this manner is subject to the conditions and limitations described
in that letter.
Your state's opioid treatment authority may impose additional requirements;
please consult with your state's opioid treatment authority to ensure your
actions are compliant with both state and federal law. Please contact your
local DEA Field Office for assistance with any of these activities.
EO-DEA163, June 9, 2020
Practitioners
Question: I am a practitioner and store controlled substances at my
practice/DEA registered location. If my registered location was damaged due
to looting/rioting or I anticipate that it may be damaged or looted, can I
move my controlled substances to another location?
Answer: Yes, you may modify your DEA registration and change your address
to another location, or to your mailing address, provided it is a physical
location and not a Post Office box, if state law permits. You may modify
your registration online. 21 CFR 1301.51. If an emergency is ongoing, DEA
is exercising its flexibility to allow you to move your controlled
substances to the new location prior to the submission of your DEA
registration modification. You must continue to comply with all security
and recordkeeping requirements, including, but not limited to, 21 CFR
1301.75(b), which requires you to store all controlled substances in a
securely locked, substantially constructed cabinet.
Further questions can be directed to your local DEA Field Office.
EO-DEA155, June 9, 2020
Pharmacy
Question: My pharmacy experienced damage due to civil unrest and now I have
damaged drugs. What should I do with them?
Answer: When possible, secure all drugs for assessment. Any controlled
substances damaged by fire or water, exposed to high temperatures, or
otherwise damaged should be collected for proper disposal. Any pharmacy
that desires to dispose of controlled substances must do so in accordance
with the DEA regulations, including recordkeeping (21 CFR Part 1317). A
pharmacy can promptly destroy controlled substances by rendering them
non-retrievable using an on-site method of destruction. See 21 CFR
1317.05(a)(1). Alternatively, a pharmacy can promptly deliver that
controlled substance to a reverse distributor's registered location by
common or contract carrier pick-up or by reverse distributor pick-up at the
pharmacy's registered location. See 21 CFR 1317.05(a)(2). EO-DEA162, June
12, 2020
Question: My pharmacy was badly damaged and I will not be able to continue
business. What steps should I take to close permanently?
Answer: If you intend to discontinue business activities altogether, please
promptly notify your local DEA Field Office. You must return your
certificate of registration for cancellation and any unexecuted order forms
(DEA 222s) to the attention of the DEA Registration Unit at 8701
Morrissette Drive, Springfield, VA 22152. 21 CFR 1301.52. You must also
dispose of any controlled substances in your inventory in accordance with
21 CFR 1317.05.
Further questions can be directed to your local DEA Field Office.
Please also contact your state regulatory boards for additional guidance.
EO-DEA166, June 10, 2020
Question: I am a pharmacist who is unable to dispense prescriptions due to
civil unrest. How can my patients obtain their controlled substance
medications?
Answer: If you are unable to conduct business, it is recommended that you
advise your patients of the following regarding how they may obtain their
controlled substance medications from another pharmacy.
DEA regulations allow for the transfer of original prescription information
for a schedule III-V controlled substance to another pharmacy for refill
purposes on a one-time basis only. However, if your pharmacy electronically
shares a real-time, online database with another pharmacy, original
prescription information may be transferred to allow that pharmacy to
refill the prescription up to the maximum number of refills permitted by
law and the prescriber's authorization. 21 CFR 1306.25(a).
Please note, all transfers must be communicated directly between two
licensed pharmacists and comply with all other applicable requirements of
21 CFR 1306.25(b)-(e).
DEA recommends that you contact your state pharmacy authority to ensure
that you remain in compliance with state pharmacy laws and guidance. Please
contact your local DEA Field Office for additional information. EO-DEA164,
June 10, 2020
Question: Could the DEA provide distributors with guidance on reporting of
suspicious orders for pharmacies that need to replenish stocks of
controlled substances lost or damaged due to looting/rioting or pharmacies
that may need to acquire additional stocks due to closure of neighboring
pharmacies?
Answer: The Controlled Substances Act requires that all DEA registrants
that distribute controlled substances report suspicious orders to DEA. 21
U.S.C. 832(a)(3). The term suspicious order "may include, but is not
limited to: (A) an order of a controlled substance of unusual size; (B) an
order of a controlled substance deviating substantially from a normal
pattern; and (C) orders of controlled substances of unusual frequency." 21
U.S.C. 802(57) and 21 CFR 1301.74(b).
DEA recognizes that a pharmacy may need to replace a substantial portion,
or all, of its controlled substance stock due to losses caused by looting
or rioting. DEA also recognizes that a pharmacy may need to order
additional stocks of controlled substances that exceed its normal ordering
patterns due to increased legitimate customer demand arising from the
closure of neighboring pharmacies.
Upon receiving orders falling within the definition of "suspicious order,"
registrants must conduct appropriate due diligence by considering all
relevant circumstances to determine if there is a legitimate basis for the
order. 21 CFR 1301.74(c). If the registrant cannot determine that the order
is legitimate, the order must be reported as suspicious. 21 CFR 1301.74(b).
EO-DEA159, June 9, 2020
Question: I have a safe in my pharmacy that I use to store schedule II
controlled substances. Can I store schedule III-V controlled substances in
the safe as well to prevent theft or loss?
Answer: Yes. You may store schedule II, III, IV, and V controlled
substances in a safe, or in a securely locked, substantially constructed
cabinet in your pharmacy to prevent theft or loss. 21 CFR 1301.75(b).
EO-DEA165, June 7, 2020
Question: My pharmacy has been looted or may be looted in the near future
as a result of the ongoing civil unrest and rioting. I don't want to change
my registered pharmacy address, but I want to move my controlled substances
stock to a secure warehouse until possible rioting or looting ends. Is it
permissible for me to do this?
Answer: You may choose to move your controlled substance and inventory to a
warehouse for storage and safekeeping under certain circumstances.
First, you should ensure that this movement of controlled substances stock
is allowed by applicable state and local law. Second, the move must be
consistent with DEA physical security regulations, including your
obligation to ensure that your controlled substances are stored securely
and otherwise protected against theft and loss. See, e.g., 21 CFR
1301.71(a), 1301.75(b).
Third, the warehouse to which you plan to move your controlled substances
inventory must either be registered with DEA or a registration exemption
must apply. In particular, you may move your controlled substance inventory
from your registered location to an unregistered warehouse for storage or
safekeeping if that inventory will thereafter be returned to you at your
original location, i.e., the same registered location from which it was
moved. If that inventory will instead be moved to another location after
being stored at the warehouse, the warehouse itself must be registered with
DEA. See 21 CFR 1301.12(b)(1).
Fourth, you must transfer any schedule II controlled substances to the
warehouse using a DEA Form 222 or the equivalent electronic order form,
unless the warehouse is exempt from the requirement of DEA registration
because, as just explained, your controlled substances will be returned to
you at your original registered location after temporary storage at the
warehouse. See 21 CFR 1305.03(a). Regardless of whether you are required to
use DEA Form 222, however, your records must reflect the movement of the
controlled substances to and (if they are returned to you) from the
warehouse.
If the option of temporary warehouse storage is allowed by state and local
law, DEA recommends you contact your local DEA Field Office regarding
further logistics of utilizing a warehouse to store controlled substances
on a temporary basis. EO-DEA161, June 7, 2020
Question: My pharmacy was looted during the riots and controlled substances
and/or scheduled listed chemical products (SLCPs) were stolen or destroyed.
How long do I have to report a theft or loss to DEA?
Answer:
Controlled Substances: 21 CFR 1301.76(b) requires that a registrant notify
their DEA Division Office, in writing, within one business day of discovery
of such theft or loss of controlled substances. A registrant can meet the
"in writing" requirement by sending an email to the below listed DEA point
of contact for your state. The registrant must also complete and submit a
DEA Form 106 online. Registrants are encouraged to perform an accounting to
determine the quantities of controlled substances lost or stolen and make
the necessary report on a DEA Form 106 as soon as practicable.
SLCPs: 21 CFR 1314.15 requires that a regulated person must, whenever
possible, orally report to their DEA Division Office any unusual or
excessive loss or disappearance of an SLCP at the earliest practicable
opportunity after the regulated person becomes aware of the circumstances
involved. A written report of loss must be filed within 15 days after the
regulated person becomes aware of the circumstances of the event. 21 CFR
1314.15(c). Section 1314.15(e) provides a suggested format for the report.
EO-DEA157, June 5, 2020
Below is a listed of each states DEA point of contact for theft or losses
during the civil unrest:
State DEA POC Email Address
Alabama DI Faith King Faith.F.King@dea.gov
Alaska DI Ariel Flores Ariel.B.Flores@dea.gov
Arizona DI Hoang Vo Hoang.A.Vo@dea.gov
Arkansas DI Mathew D. Bissonnette Matthew.D.Bissonnette@dea.gov
California (Middle) DI Veronica Corona Veronica.Corona@dea.gov
California (Northern) GS Lynnette Wingert Lynnette.M.Wingert@dea.gov
California (Southern) San Diego & Imperial Counties Pamela S. Meyer Pamela.S.Meyer@dea.gov
Caribbean DPM Silvia N. Colon Silvia.N.Colon@dea.gov
Colorado Deanna Bell Deanna.R.Bell@dea.gov
Connecticut D/I Javier Cruz Jesus.J.Cruz@dea.gov
Delaware Gabrielle Stern Gabrielle.N.Stern@dea.gov
District of Columbia GS Dianne Kellum Dianne.M.Kellum@dea.gov
Florida A/DPM James Graumlich James.W.Graumlich@dea.gov
Georgia GS David F. Graham David.F.Graham@dea.gov
Hawaii GS Gary Whisenand Gary.L.Whisenand@dea.gov
Idaho 208-386-2100 Boise.Diversion.Mail@dea.gov
Illinois (Northern half) Megan N. Almendinger Megan.N.Almendinger@dea.gov
Illinois (Southern half) DI Mark Gman Mark.J.Grman@dea.gov
Indiana (Northern half) Michael J. Feraldo Michael.J.Feraldo@dea.gov
Indiana (Southern half) Billy P. Lane Billy.P.Lane@dea.gov
Iowa DI Amy Nelson Amy.J.Nelson@dea.gov
Kansas GS Dwayne Holsapple Hugh.D.Holsapple@dea.gov
Kentucky GS Ben Vinson Benjamin.S.Vinson@dea.gov
Louisiana DI William K. Wilson William.K.Wilson@dea.gov
Maine Emma Hinnigan Emma.J.Hinnigan@dea.gov
Maryland GS Niketa Prince Niketa.G.Prince@dea.gov
Massachusetts Taylor McCarty Taylor.A.McCarty@dea.gov
Michigan Kathy L. Federico Kathy.L.Federico@dea.gov
Minnesota GS Chenin Donahue Chenin.A.Donahue@dea.gov
Mississippi DI Christopher Martinez Christopher.M.Martinez@dea.gov
Missouri DI Mark Gman Mark.J.Grman@dea.gov
Montana DI Alida Lefebvre Alida.M.Lefebvre@dea.gov
Nebraska GS Shannon Keller Shannon.B.Keller@dea.gov
Nevada GS Jayne Griffin Jayme.M.Griffin@dea.gov
New Hampshire Frank Borelli Frank.J.Borelli@dea.gov
New Jersey DI Jason Martino (Camden) Jason.M.Martino@dea.gov
New Jersey DI Tony Rego Anthony.Rego@dea.gov
New Mexico DPM Heather McMurry Heather.McMurry@dea.gov
New York City, Long Island, & Surrounding DI Jonathan Rivera Jonathan.L.Rivera@dea.gov
New York Upstate DI Kevin O'Neil Kevin.M.Oneil@dea.gov
North Carolina GS Stephanie A. Evans Stephanie.A.Evans@dea.gov
North Dakota GS Chenin Donahue Chenin.A.Donahue@dea.gov
Ohio Central - Columbus Sandra White-Hope Sandra.K.White-Hope@dea.gov
Ohio Southern-Cincinnati Linda Staller Linda.S.Staller@dea.gov
Ohio Northern - Cleveland Steve Moluse Cleveland.Diversion@dea.gov
Oklahoma Lisa Sullivan Lisa.D.Sullivan@dea.gov
Oregon 503-721-6660 Portland.Diversion@dea.gov
Pennsylvania (Eastern) Jill Dunphy Julianne.X.Dunphy@dea.gov
Pennsylvania (Western) Nancy Jackson Nancy.Jackson2@dea.gov
Pennsylvania (Middle) Dominic Johnson Dominic.D.Johnson@dea.gov
Rhode Island Thomas Cook Thomas.A.Cook@dea.gov
South Carolina GS Adam H. Roberson Adam.H.Roberson@dea.gov
South Dakota GS Shannon Keller Shannon.B.Keller@dea.gov
Tennessee GS James Stevens James.N.Stevens@dea.gov
Texas (North) Lisa Sullivan Lisa.D.Sullivan@dea.gov
Texas (South) Heidi Carroll Heidi.J.Carroll@dea.gov
Texas (West) DPM Heather McMurry Heather.McMurry@dea.gov
Utah DI Alida Lefebvre Alida.M.Lefebvre@dea.gov
Vermont Christopher Pasquette Christopher.L.Paquette@dea.gov
Virginia (Eastern) GS Edward Logan Edward.M.Logan@dea.gov
Virginia (Central) GS Coralie Terpening Coralie.A.Terpening@dea.gov
Virginia (Western) GS Jennifer Reed Jennifer.Reed5@dea.gov
Washington 206-553-5990 Seattle.Diversion@dea.gov
West Virginia A/GS Heather Wehrle Heather.L.Wehrle@dea.gov
Wisconsin Laura Reid Laura.Reid@dea.gov
Wyoming Deanna Bell Deanna.R.Bell@dea.gov
Disclaimer: Guidance documents, like this document, are not binding and
lack the force and effect of law, unless expressly authorized by statute or
expressly incorporated into a contract, grant, or cooperative agreement.
Consistent with Executive Order 13891 and the Office of Management and
Budget implementing memoranda, the Department will not cite, use, or rely
on any guidance document that is not accessible through the Department's
guidance portal, or similar guidance portals for other Executive Branch
departments and agencies, except to establish historical facts. To the
extent any guidance document sets out voluntary standards (e.g.,
recommended practices), compliance with those standards is voluntary, and
noncompliance will not result in enforcement action. Guidance documents may
be rescinded or modified in the Department's complete discretion,
consistent with applicable laws.
REGISTRATION
REPORTING
RESOURCES
CONTACT US
PRIVACY NOTICE
GET EMAIL UPDATES
Get Email Updates
×
Official U.S. Department of Justice Seal
The United States Department of Justice
You are now leaving a Department of Justice Web site.
You are about to access:
Email Updates
The Department of Justice does not endorse the organizations or views
represented by this site and takes no responsibility for, and exercises no
control over, the accuracy, accessibility, copyright or trademark
compliance or legality of the material contained on this site.
Thank you for visiting our site.
DEA.GOV
JUSTICE.GOV
USA.GOV
REGULATIONS.GOV
DOJ Privacy Policy
Section 508 Accessibility
DOJ Legal Policies & Disclaimers
FOIA
DIVERSION CONTROL DIVISION
U.S. Department of Justice
Drug Enforcement Administration
DIVERSION CONTROL DIVISION
8701 Morrissette Drive
Springfield, VA 22152
1.800.882.9539
|
|---|
|
